Maternal outcome in pregnancy complicated with pulmonary arterial hypertension

Circulation Journal

Volumn 76, Issue 9, 2012, Pages 2249-2254

  Katsuragi, Shinji ^a   Yamanaka, Kaoru ^a   Neki, Reiko ^a   Kamiya, Chizuko ^a   Sasaki, Yoshihito ^a   Osato, Kazuhiro ^a   Miyoshi, Takekazu ^a   Kawasaki, Kaoru ^a   Horiuchi, Chinami ^a   Kobayashi, Yoshinari ^a   Ueda, Keiko ^a   Yoshimatsu, Jun ^a   Niwa, Koichiro ^b   Takagi, Yaemi ^c   Ogo, Takeshi ^c   Nakanishi, Norifumi ^c   Ikeda, Tomoaki ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

^c Pulmonary Circulation Group   (Japan)

Author keywords

Eisenmenger syndrome; Pregnancy; Pulmonary arterial hypertension

Indexed keywords

DOBUTAMINE; PROSTACYCLIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTINUOUS INFUSION; DISEASE SEVERITY; DRUG DOSE INCREASE; ECHOCARDIOGRAPHY; FEMALE; FETUS DEATH; GESTATIONAL AGE; HEART CATHETERIZATION; HEART CONTRACTION; HEART FUNCTION; HEART VENTRICLE SIZE; HUMAN; INTRAUTERINE GROWTH RETARDATION; JAW PAIN; LABOR STAGE; LUNG ARTERY PRESSURE; PREGNANCY OUTCOME; PREGNANCY TERMINATION; PULMONARY HYPERTENSION; PULMONARY VALVE INSUFFICIENCY; SMALL FOR DATE INFANT; SYSTOLIC BLOOD PRESSURE; TRICUSPID VALVE REGURGITATION;

ADULT; BLOOD PRESSURE; EISENMENGER COMPLEX; FEMALE; HUMANS; HYPERTENSION, PULMONARY; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES;

EID: 84865463911     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-12-0235     Document Type: Article

References (37)

1. Miyamichi-Yamamoto S, Fukumoto Y, Sugimura K, Ishii T, Satoh K, Miura Y, et al. Intensive immunosuppressive therapy improves pulmonary hemodynamics and long-term prognosis in patients with pulmonary arterial hypertension associated with connective tissue disease. Circ J 2011; 75: 2668-2674.
2. Takeuchi K, Watanabe H. Pulmonary arterial hypertension associated with connective tissue disease and immunosuppressive therapy. Circ J 2011; 75: 2543-2544.
3. Fishman AP. Clinical classification of pulmonary hypertension. Clin Chest Med 2001; 22: 385-391.
4. Galiè N, Hoeper MN, Humbert M, Torbicki A, Vachiery JL, Barbera JA, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009; 30: 2493-2537.
5. Fukumoto Y, Shimokawa H. Recent progress in the management of the pulmonary hypertension. Circ J 2011; 75: 1801-1810.
6. Diller GP, Gatzoulis MA. Pulmonary vascular disease in adults with congenital heart disease. Circulation 2007; 115: 1039-1050.
7. van Loon RL, Roofthooft MT, Delhaas T, van Osch-Gevers M, ten Harkel AD, Strengers JL, et al. Outcome of pediatric patients with pulmonary arterial hypertension in the era of new medical therapies. Am J Cardiol 2010; 106: 117-124.
8. A Satoh T, Saji T, Watanabe H, Ogawa S, Takehara K, Tanabe N, et al. Phase III multicenter, collaborative, open-label clinical trial of sildenafil in Japanese patients with pulmonary arterial hypertension. Circ J 2011; 75: 677-682.
9. Rubin LJ, Badesch DB, Barst RJ, Galie N, Black CM, Keogh A, et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 2002; 346: 896-903.
10. Watanabe H, Ohashi K, Takeuchi K, Yamashita K, Yokoyama T, Tran QK, et al. Sildenafil for primary and secondary pulmonary hypertension. Clin Pharmacol Ther 2002; 71: 398-402.
11. Galiè N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LJ, Badesch D, et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 2005; 353: 2148-2157.
12. Galiè N, Brundage BH, Ghofrani HA, Oudiz RJ, Simonneau G, Safdar Z, et al. Tadalafil therapy for pulmonary arterial hypertension. Circulation 2009; 119: 2894-2903.
13. Keogh AM, Mayer E, Benza RL, Corris P, Dartevelle PG, Frost AE, et al. Interventional and surgical modalities of treatment in pulmonary hypertension. J Am Coll Cardiol 2009; 54: S67-S77.
14. Orens JB, Estenne M, Arcasoy S, Conte JV, Corris P, Egan JJ, et al. International guidelines for the selection of lung transplant candidates: 2006 update: A consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006; 25: 745-755.
15. Dawkins KD, Burke CM, Billingham ME, Jamieson SW. Primary pulmonary hypertension and pregnancy. Chest 1986; 89: 383-388.
16. Roberts NV, Keast PJ. Pulmonary hypertension and pregnancy: A lethal combination. Anaesth Intensive Care 1990; 18: 366-374.
17. Smith JS, Mueller J, Daniels CJ. Pulmonary arterial hypertension in the setting of pregnancy: A case series and standard treatment approach. Lung 2012; 190: 155-160.
18. Weiss BM, Zemp L, Seifert B, Hess OM. Outcome of pulmonary vascular disease in pregnancy: A systematic overview from 1978 through 1996. J Am Coll Cardiol 1998; 31: 1650-1657.
19. Lam GK, Stafford RE, Thorp J, Moise KJ Jr, Cairns BA. Inhaled nitric oxide for primary pulmonary hypertension in pregnancy. Obstet Gynecol 2001; 98: 895-898.
20. Bendayan D, Hod M, Oron G, Sagie A, Eidelman L, Shitrit D, et al. Pregnancy outcome in patients with pulmonary arterial hypertension receiving prostacyclin therapy. Obstet Gynecol 2005; 106: 1206-1210.
21. Sigel CS, Harper TC, Thorne LB. Postpartum sudden death from pulmonary hypertension in the setting of portal hypertension in the setting of portal hypertension. Obstet Gynecol 2007; 110: 501-503.
22. Weiss BM, Hess OM. Pulmonary vascular disease and pregnancy: Current controversies, management strategies, and perspectives. Eur Heart J 2000; 21: 104-105.
23. Easterling TR, Ralph DD, Schmucker BC. Pulmonary hypertension in pregnancy: Treatment with pulmonary vasodilators. Obstet Gynecol 1999; 93: 494-498.
24. Goto K, Arai M, Watanabe A, Nakano A, Kurabayashi M. Utility of echocardiography versus BNP level for the prediction of pulmonary arterial pressure in patients with pulmonary arterial hypertension. Int Heart J 2010; 51: 343-347.
25. Casserly B, Klinger JR. Brain natriuretic peptide in pulmonary arterial hypertension: Biomarker and potential therapeutic agent. Drug Des Dev Ther 2009; 3: 269-287.
26. Diller GP, Gatzoulis MA. Pulmonary vascular disease in adults with congenital heart disease. Circulation 2007; 115: 1039-1050.
27. Waners CA. Pregnancy and pulmonary hypertension. Int J Cardiol 2004; 97: 11-13.
28. Dang Z, Morse JH, Slager SI, Cuervo N, Moore KJ, Venetos G, et al. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor II gene. Am J Hum Genet 2000; 67: 737-744.
29. Sztrymf B, Yaïci A, Girerd B, Humbert M. Genes and pulmonary arterial hypertension. Respiration 2007; 74: 123-132.
30. Elliot CA, Stewart P, Webster VJ, Mills GH, Hutchinson SP, Howarth ES, et al. The use of iloprost in early pregnancy in patients with pulmonary arterial hypertension. Eur Respir J 2005; 26: 168-173.
31. Bédard E, Dimopoulos K, Gatzouli MA. Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension? Eur Heart J 2009; 30: 256-265.
32. McIlduff JB, Daggett WM, Buckley MJ, Lappas DG. Systemic and pulmonary hemodynamic changes immediately following mitral valve replacement in man. J Cardiovasc Surg 1980; 21: 261-266.
33. Foltz BD, Hessel EA 2nd, Ivey TD. The early course of pulmonary artery hypertension in patients undergoing mitral valve replacement with cardioplegic arrest. J Thorac Cardiovasc Surg 1984; 88: 238-247.
34. Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. 9th edn, revised. Little, Brown & Co, Boston, 1994.
35. Pitkin RM, Perloff JK, Koos BJ, Beall MH. Pregnancy and congenital heart disease. Ann Intern Med 1990; 112: 445-454.
36. Yanagisawa R, Kataoka M, Taguchi H, Kawakami T, Tamura Y, Fukuda K, et al. Impact of first-line sildenafil monotreatment for pulmonary arterial hypertension. Circ J 2012; 76: 1245-1252.
37. Penning S, Robinson KD, Major CA, Garite TJ. A comparison of echocardiography and pulmonary artery catheterization for evaluation of pulmonary artery pressures in pregnant patients with suspected pulmonary hypertension. Am J Obstet Gynecol 2001; 184: 1568-1570.